Twitter Beğeni Hilesi

Clinically relevant survival differences, a report from the CATNON trial: Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations Acta Neuropathologica DOI 0.1007/s00401-021-02291-6

Important to realise: Association between socioeconomic status and survival in glioblastoma: An Italian single-centre prospective observational study. Tosoni A,Brandes AA. Eur J Cancer doi:10.1016/j.ejca.2020.12.027

change has come. our brain tumor board today 8 females, 2 males. excellent discussions!

have been reviewing abstracts for the upcoming EANO 2021 meeting: great abstracts! this will be a good meeting! be sure to attend!

BREAKING: New #EANO guideline on the diagnosis and management of meningiomas has just been published in Neuro-Oncology. Learn more➡️ doi.org/10.1093/neuonc… #NeuroOncology #meningioma #MolecularPathology #neuropathology #radiosurgery #surgery SNO Roland Goldbrunner OncoAlert

The revised EANO guideline on meningioma will help to keep our colleagues and patient care up to date! doi.org/10.1093/neuonc…

EANO 2021 is coming up: 12 more days before Europe's largests and most informative neuro-oncology meeting starts! I look forward to learning from my colleagues!

The EANO 2021 annual meeting is approaching. It's a great program with toplevel abstract, thus register now! The success depends on its participants!

All you want to know about novel radiotherapy techniques and brain tumor plasticity: EANO 2021 is almost starting. Don't miss it!

At EANO 2021, florence laigle-donadey providers the long-needed evidence to the role of surgery in elderly glioblastoma patients

EANO 2021 was a top class event with scientific advances and top class overviews. Talks will be made available off line for the registrants.

This is a threat to our world. bbc.com/news/uk-589241…

proud of the new EANO-SNO-EURACAN guideline on intracranial germinoma: guidenance for clinicians facing a challenging disease with favorable outcome if well managed: doi.org/10.1093/neuonc… Thank you didier frappaz for leading this effort!

Testing for MGMT in IDHmt tumors not very useful: more data from the CATNON trial: Neuro-Oncology, noac014, doi.org/10.1093/neuonc…

Joint Final Report of EORTC 26951 and RTOG 9402: ascopubs.org/doi/pdf/10.120… Two academic trials confirming each other inb one publication: who had anticipated 30% PFS after radiotherapy and PCV in anaplastic 1p/19q CODEL 20 years ago?

Critical review of the report on the DCvax-L trial: the trial did not meet its prospectively defined endpoint and post-hoc analyses with poorly selected external controls do not replace a proper prospective trial academic.oup.com/neuro-oncology…

EANO provides major guideline on rational and effective molecular testing for targeted treatments in brain tumors: a powerful help for clinicians academic.oup.com/neuro-oncology…

Primary brain tumours in adults - The Lancet thelancet.com/journals/lance…

Wonderful to see this review on primary brain tumors appear in the Lancet on the eve EANO 2023 in Rotterdam starts!

Last Day of EANO 2023: large audience attending EANO - EANM session!